Dr. Agarwal's Eye Hospital Limited has made a disclosure regarding its Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The company has sent email communications and dispatched physical letters to equity shareholders whose email addresses are not registered or available with the company, Registrar and Transfer Agents, Depository Participants, or Depositories.

Key Details of Amalgamation

The Hon'ble National Company Law Tribunal (NCLT), Chennai Bench, sanctioned the Scheme of Amalgamation under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 through its order dated September 30, 2026.

Record Date

The Board of Directors of the Company, in consultation with the Board of the Transferee Company, has fixed Wednesday, November 18, 2026, as the Record Date for determining eligible equity shareholders who shall be entitled to receive fully paid-up equity shares of the Transferee Company.

Share Exchange Ratio

Pursuant to Clause 18.1 of the Scheme, eligible shareholders of Dr. Agarwal's Eye Hospital Limited will receive 23 Equity Shares of face value ₹1/- each fully paid-up in Dr. Agarwal's Health Care Limited for every 2 Equity Shares of face value ₹10/- each fully paid-up held in Dr. Agarwal's Eye Hospital Limited as on the Record Date.

Treatment of Fractional Entitlements

No fractional equity shares will be issued directly to any shareholder. Fractional entitlements will be consolidated and allotted to a Trustee nominated by the Board (Trustee 1), who will hold these shares in trust on behalf of eligible shareholders. The Trustee will sell these consolidated shares on the Stock Exchanges at market price within 90 days from the date of allotment and distribute the net proceeds (after deducting applicable costs, expenses, and withholding taxes) to eligible shareholders in proportion to their respective fractional entitlements.

Mode of Allotment

For shares held in demat mode: New equity shares of Dr. Agarwal's Health Care Limited will be allotted in dematerialised form and credited directly to beneficiaries' demat accounts after obtaining necessary regulatory and stock exchange approvals.

For shares held in physical mode: Equity shares will be credited in dematerialized form to a dedicated Trustee Demat Account and held in trust until beneficiaries submit and verify requisite demat details and documents. Shareholders holding physical shares are strongly recommended to dematerialize their share certificates prior to November 18, 2026.

Registrar and Transfer Agent Details

Integrated Registry Management Services Private Limited serves as the RTA, located at 2nd Floor, Kences Towers, No.1 Ramakrishna Street, North Usman Road, T Nagar, Chennai – 600 017. Contact: (044) 2814 0801 / 803, Email: einward@integratedindia.in.

Additional Communication

A separate communication/advice will be sent to eligible shareholders post allotment and credit of the consideration shares.